Literature DB >> 26346096

Drug-induced Telogen Effluvium in a Pediatric Patient due to Error of Transcription.

Stephanie Feldstein1, Smita Awasthi2, Andrew C Krakowski1.   

Abstract

"Errors of transcription" are rarely reported, but may cause significant adverse effects in patients. Here, the authors report the case of a 15-year-old Burmese girl presenting with telogen effluvium after being dispensed the wrong medication due to a pharmacy auto-complete error.

Entities:  

Year:  2015        PMID： 26346096      PMCID： PMC4557852     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  6 in total

1.  Reported medication errors after introducing an electronic medication management system.

Authors:  Bernice Redley; Mari Botti
Journal:  J Clin Nurs       Date:  2012-09-24       Impact factor: 3.036

2.  The effects of electronic prescribing by community-based providers on ambulatory medication safety.

Authors:  Erika L Abramson; Elizabeth R Pfoh; Yolanda Barrón; Jill Quaresimo; Rainu Kaushal
Journal:  Jt Comm J Qual Patient Saf       Date:  2013-12

3.  Drug complications in outpatients.

Authors:  T K Gandhi; H R Burstin; E F Cook; A L Puopolo; J S Haas; T A Brennan; D W Bates
Journal:  J Gen Intern Med       Date:  2000-03       Impact factor: 5.128

4.  Evaluation of language concordant, patient-centered drug label instructions.

Authors:  Stacy Cooper Bailey; Urmimala Sarkar; Alice Hm Chen; Dean Schillinger; Michael S Wolf
Journal:  J Gen Intern Med       Date:  2012-03-27       Impact factor: 5.128

Review 5.  Drugs and hair loss.

Authors:  Mansi Patel; Shannon Harrison; Rodney Sinclair
Journal:  Dermatol Clin       Date:  2012-09-18       Impact factor: 3.478

6.  From physician intent to the pharmacy label: prevalence and description of discrepancies from a cross-sectional evaluation of electronic prescriptions.

Authors:  Gary L Cochran; Donald G Klepser; Marsha Morien; Daniel Lomelin; Rebecca Schainost; Lina Lander
Journal:  BMJ Qual Saf       Date:  2013-10-08       Impact factor: 7.035
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.